Kivu plans to start its first clinical trial in solid tumors next year.
Founders
Mohit Trikha
Company Description
Kivu Biosciences is a biotechnology startup developing targeted drugs for cancer, focusing on antibody-drug conjugates (ADCs) that are more precise and stable, aiming to reduce side effects.
Market
Cancer treatment
Location
San Francisco,
California,
USA
Coinvestors
Novo Holdings, Gimv, Red Tree Venture Capital, BioGeneration Ventures